Subject: Re: Benchmark Investing Update March 27, 2026
With this week's update Apr. 24, 2026

SELL: SLB is now overpriced according to BI formula. BI Downside target +14%.
BUY: DIS meets all buy requirements. BI Downside target -29%.
BUY: OMC meets all buy requirements. BI Downside target -29%.